Exo-PASS Exosomes contain proteins, lipids, nucleic acids, and metabolites, and can be easily enriched from biofluids, providing very valuable information for early detection and monitoring of diseases. The Ministry of Food and Drug Safety requires RNA, lipid and proteomic analyses in its guidelines for the development of exosome therapeutics, and PASS provides these analyses in an all-in-one package. Exosome RNA Sequencing: PASS enables rapid and efficient isolation of RNAs and profiling of exosome nucleic acids using qRT-PCR and novel sequencing methods. Exosome Lipidomics: We perform high-reliability and high-sensitivity analysis through an ultra-high-performance tool (UPLC, Orbitrap Exploris 480 MS) and lipid analysis experts who have been producing and interpreting analysis data for many years. Exosome Proteomics: PASS offers and performs quantification analysis that meets customer needs based on the unique expertise in exosome protein extraction. We provide reliable results through deep profiling of exosome proteome and a specialized data library. Our world-class bioinformatics research team at Bertis reviews and interprets pan-omics data (RNA/Lipid) to support in-depth research.
PASS is an analysis solution optimized for academia and pharma research. The proprietary solution was derived from proven technology and innovation embedded in Mastocheck, a proteomics-based early cancer diagnostics approved by Ministry of Food and Drug Safety (MFDS). Bertis developed the PASS solution based on its pan-omics, bioinformatics, and artificial intelligence (AI) technologies. We provide a variety of analyzes for proteomic analysis, biomarker discovery and verification, new drug development, clinical process development, etc. PASS is a platform for integrative analysis of pan-omics data, based on our proven and reliable bioinformatics analysis capabilities. Our team consists of experienced scientists with an extensive track record of research achievements spanning more than a decade in mass spectrometry-based proteomics. Bertis possesses the core expertise and proprietary technology for pan-omics (multi-omics) analysis to provide customized solutions in all fields where omics data analysis is applicable. With PASS, you can leverage Bertis scientific resources and cutting-edge tools to advance your research projects and goals, from the design stage to the interpretation and visualization of bioinformatics analysis results.
Proteomics-based Early diagnosis using multiple markers provides a quick and accurate solution for early diagnosis of major diseases by utilizing multiple proteomic biomarker-based blood tests. Early diagnostic solutions BERTIS has commercialized MASTOCHECK, the worlds first proteomics-based blood test solution for early diagnosis of breast cancer, and clinical trials are being conducted on biomarkers for various cancers. Ultimately, these technologies are being used to continually expand the pipeline to allow dozens of diseases to be diagnosed with a single blood test.
Biomarker Diseases Diagnosis Blood Tests Proteomics-based early diagnosis Provides a quick and accurate solution for early diagnosis of major diseases by utilizing multiple proteomic biomarker-based blood tests. Advantages of proteomics-based early diagnosis: Proteomics-based early diagnosis determines the presence of disease by identifying proteins that are specifically expressed in diseases and using these as biomarkers to measure the quantitative values of the relevant proteins in blood. Proteomics analysis has been assessed as highly likely to be used as a universal primary screening method because analysis can be performed even with trace samples, such as a few drops of blood.
PC-PASS Protein Characterization Analysis Protein Characterization (Physicochemical property of proteins) structure analysis using mass spectrometry provides results that meet the requirements of the FDA, the MFDS and other regulatory authorities regarding novel therapies or biosimilars. Based on basic amino acid analysis (full sequencing), we perform post-translational modification (PTM) analysis, which is important for protein potency and stability. In this regard, we can perform test methods based on design of experiment (DOE) statistical methodology and deliver documents to be submitted to regulatory authorities. Protein identification and quantification : Structural analysis of all types of protein therapeutics, including monoclonal antibodies (mAbs), antibody-drug conjugates (ADCs), and enzymes - Full Length-Amino acids sequencing Peptide identification of each peak through peptide mapping (MS spectrum confirmation, MS/MS spectral analysis with 100% AA matches) - Improved N- and C-terminal sequencing of proteins Post-translational modification (PTM) : More reliable results based on design of experiment (DOE) statistical methodology to perform the experiments systematically and analyze data efficiently - Disulfide bond analysis ID Total possible lankage analysis - Deamidation identification and quantification - Phosphorylation identification and quantification , phospho-proteomic analysis - Other functional modifications Glycomics : Single protein analysis and research of protein complexes with glycosylation closely related to biological function and toxicity as well as structural stability of proteins - Glycosylation site determination - Glycan profiling - Site-specific glycan identification and quantification - Glycomics research with glycan enrichment
One step, rapid immunochromatographic assay for detectionof NS1Ag of all serotypes of Dengue virus in human serum orplasmaDetection of infection prior to sero - conversionDetects all serotypes (DEN-1,DEN-2,DEN-3, DEN-4)Specimen volume : 90 - 100 ul of Serum/PlasmaNo sample preparation requiredResult interpretation time: 20 minsSensitivity :> 95%. Specificity : =95%
Testing 1
Test Test Test Test Test Test
test test test test test test test test test test test test test test test test test test test test test test test test test test test
CE Certified Assay+ Covid 19 IgG / IgM Rapid Test Assay+ Covid 19 antibody rapid test is manufactured in Canada to detect specific Covid 19 IgG and IgM for the healthcare providers. Assay+ COVID-19 Rapid Test Kit is qualitative test device for SARS-CoV-2 IgM/IgG antibodies in human serum, plasma, whole blood or finger tip blood. This device has been authorized by CE Mark and waiting for FDA approval. Sensitivity over 90 for IgM and 95-100% for IgG and 100% specifity have been proved used by our customers in large quantity and tested by multiple clinical agreement studies in the University Medical Center, Brooklyn at New York, USA , Henry Ford Hospital at Michigan, USA, we'll supply the high quality product for our customers. You can visit our web site https://bioassayplus.com, email: info@immunoassay.ca, or marketing@bioassayplus.com, or call phone 313 455 0968. New test is under the way: 1. Covid 19 antigen rapid test 2. Covid 19 protective antibody and titer rapid test ( Test antibody reaction after taking Covid 19 vaccine) 3. We also supply raw materials for diagnostic industry, please check Bioassayplus.com Package and Price for Covid 19 IgG/IgM rapid test: 25 test kits per box 100 to 2500, 1.99 USD per test, 2501 to 4999, 1.80 USD per test 5000 to 50,000, 1.75 USD per test 50,000 to 1000, 000 or more, 1.65 USD per test
CE marked Dengue virus IgG/IgM rapid test Assay+ Dengue IgG/IgM antibody rapid test is manufactured in Canada to detect specific dengue IgG and IgM for the healthcare providers. Assay+ dengue IgG/IgM Rapid Test Kit is qualitative test device for dengue virus IgM/IgG antibodies in human serum, plasma, whole blood or finger tip blood. This device has been authorized by CE Mark. Sensitivity over 90% for IgM and IgG and 100% specificity have been proved used by our customers in large quantity.
Assay+ Ebola IgG /IgM antibody rapid test is manufactured in Canada to detect specific Ebola IgG and IgM for the healthcare providers. Assay+ Ebola IgG / IgM Rapid Test Kit is qualitative test device for Ebola IgG/IgMantibodies in human serum, plasma, whole blood or finger tip blood. This device has been tested in large quantity in Ebola pandemic region. Sensitivity over 90% for IgM and IgG and 100% specificity have been proved used by our customers in large quantity.
Assay+ Zika antibody rapid test is manufactured in Canada to detect specific Zika IgG and IgM for the healthcare providers. Assay+ Zika Rapid Test Kit is qualitative test device for Zika IgM/IgG antibodies in human serum, plasma, whole blood or finger tip blood. This device has been used by our end customers with large quantitiy. Sensitivity over 65% for IgM and 85% for IgG and 100% specificity have been proved used by our customers in large quantity.
CE Certified Assay+ Covid 19 IgG / IgM Rapid Test Assay+ Covid 19 antibody rapid test is manufactured in Canada to detect specific Covid 19 IgG and IgM for the healthcare providers. Assay+ COVID-19 Rapid Test Kit is qualitative test device for SARS-CoV-2 IgM/IgG antibodies in human serum, plasma, whole blood or finger tip blood. This device has been authorized by CE Mark and waiting for FDA approval. Sensitivity over 90% for IgM and 100% for IgG and 100% specifity have been proved used by our customers in large quantity and tested by multiple clinical agreement studies in the University Medical Center, Brooklyn at New York, USA , Henry Ford Hospital at Michigan, USA, we'll supply the high quality product for our customers.
Assay+ dengue NS1 antigen rapid test is manufactured in Canada to detect dengue antigen for the healthcare providers. Assay+ dengue NS1 Rapid Test Kit is qualitative test device for dengue NS1 infection from human serum or plasma.. This device has been used by our end customers with large quantity. Sensitivity over 80% and 100% specificity have been proved used by our customers in large quantity.
Assay+ Coivd 19 Neutralizing antibody rapid test is manufactured in Canada to detect specific Covid 19 neutralizing IgG for the healthcare providers. Assay+ neutralizing Covid 19 antibody Rapid Test Kit is qualitative test device, but it can monitor the neutralizing antibody titer. This test can detect the neutralizing antibody from human serum, plasma, whole blood or finger tip blood. This device has been used by our end customers with good feedback.
Antibody And Antigen Test Kits.
Rapid antigen test kits.
Accu check active test strip and performa strips.
Rapid test kits.
